Exciting times ahead26 May 2019 16:42
So much newsflow due and imo the £80k was a sell, think a spreadex TR1 will land Tuesday then 10p+ before NPX001 results, which fingers crossed will be positive.Last interview with Dan, patients were discharged weeks ago and they are looking at how quick they can get their product to the market, sounds positive.
To become a Unicorn (£1B valuation, around 216pps) NFX only need (for NPX002 alone):
@10% royalies
£70,000 per patient year drug cost
~20% overhead
ONLY around 9,000 patients
The US has 100,000 IPF sufferers, China and EU, multiple of that